We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The Idylla microsatellite instability (MSI) assay cartridge (Photo courtesy of Biocartis).

Microsatellite Instability Assay Validated for Cancer Studies

Microsatellite instability (MSI) occurs when mismatch repair proteins (MMR) fail to fix a DNA replication error, leading to frame-shift mutations in a person's genetic code and non-functioning proteins. MSI has acted as a strong marker for genetic conditions such as Lynch syndrome that can lead to a variety of cancers. More...
20 Nov 2018
Image: A diagram workflow of the ThyroSeq Genomic Classifier assay to determine preoperative thyroid cancer status (Photo courtesy of ThyroSeq).

Genetic Test Helps Patients Avoid Unnecessary Thyroid Surgery

A genetic test has been developed that can help avoid costly diagnostic surgery that involves removing one or both lobes of the thyroid gland, by reliably distinguishing between benign and cancerous thyroid nodules using a very small sample of cells. More...
19 Nov 2018
Image: The HSV2 ELITe MGB Kit is a real-time PCR assay designed for the detection and quantification of type 2 herpes simplex virus DNA (Photo courtesy of EliTech Group).

Herpes Simplex Virus Assay, Sample-to-Answer Instrument Get FDA Clearance

Herpes simplex virus 2 (HSV2) is a widespread herpes virus, usually sexually transmitted and responsible for genital herpes. Herpes simplex virus 1 (HSV1) is a common virus life-long established in the peripheral nervous system. More...
14 Nov 2018
Image: Immunostaining of breast cancer; distribution pattern of the Ki67 labeling index in breast cancer values (Photo courtesy of University of Szeged).

Breast Cancer Risk Variant Type Determines Tumor Aggressiveness

Interval breast cancer is a term for tumors detected within a year after a mammographic screening that was determined to be normal and is among the measures used to gauge the efficacy of breast screening programs. More...
14 Nov 2018
Image: Bone marrow aspirate from a patient with multiple myeloma showing plasmacytosis (Photo courtesy of Feinberg School of Medicine).

RNA Defects Linked to Multiple Myeloma Progression

Multiple myeloma (MM) is the second most common type of blood cancer where cancer cells accumulate in the bone marrow, crowding out healthy blood cells. Studies on MM development have traditionally focused mostly on DNA abnormalities. More...
14 Nov 2018
Image: The ID Core XT blood group genotyping kit (Photo courtesy of Progenika Biopharma).

Blood Compatibility Assay Approved by FDA

Blood can be grouped based on the antigens on the surfaces of red blood cells, and the presence or absence of blood group antigens other than the ABO blood group antigens can be important in matching blood for transfusions. More...
12 Nov 2018
Image: A photomicrograph of heart cells (Photo courtesy of Cedars-Sinai Medical Center).

Blood Test Identifies Heart Failure with Preserved Ejection Fraction

A test based on a protein biomarker found in the blood is the basis of a scoring system that distinguishes patients with clinical heart failure with preserved ejection fraction (HFpEF) from healthy individuals and patients with risk factors but no heart failure. More...
12 Nov 2018
Visit expo >
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gel Cards
DG Gel Cards

In Other News



Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000 - 2025 Globetech Media.
All rights reserved.
GLOBE SCIENTIFIC, LLC